Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: Mol Cancer Ther. 2014 Feb 19;13(4):986–995. doi: 10.1158/1535-7163.MCT-13-0801

Figure 4. In Vivo Subcellular Distribution.

Figure 4

Olaparib-BODIPY FL shows predominantly nuclear and nucleolus uptake after 218 min while olaparib-BODIPY 650 is located primarily in the perinuclear region. Scale bar = 20 μm